Related Experiment Video
Updated: Jul 12, 2025
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future
Fabio Conforti1, Laura Pala1, Tommaso De Pas1
1Department of Medical Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy.
Summary
Improving adjuvant endocrine therapy (ET) for early-stage breast cancer requires rigorous research. Future efforts should focus on patient subgroups, treatment optimization, and understanding biological effects for better outcomes.
Area of Science:
- Oncology
- Endocrinology
- Cancer Research
Background:
- Adjuvant endocrine therapy (ET) is crucial for early-stage breast cancer.
- Improving ET efficacy faces challenges despite new drugs and technologies.
Purpose of the Study:
- To discuss key principles for future research to enhance adjuvant ET efficacy.
- To identify critical areas for improving ET in breast cancer treatment.
Main Methods:
- Critical discussion of research principles for ET improvement.
- Identification of four key issues in adjuvant ET.
Main Results:
- Future ET improvement necessitates rigorous research in under-investigated areas.
- Key areas include tailoring ET duration, optimizing ovarian function suppression, understanding estrogen receptor biology, and refining treatment escalation selection.
Conclusions:
- Applying rigorous research principles to specific ET challenges can yield significant advancements.
- Personalized approaches in ET are essential for optimizing breast cancer treatment outcomes.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K